Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The development of polyplex-based DNA vaccines.

Kenneth Alan Howard1, H Oya Alpar

  • 1Centre for Drug Delivery Research, School of Pharmacy, University of London, UK.

Journal of Drug Targeting
|June 21, 2002
PubMed
Summary

DNA vaccines offer new possibilities for disease prevention and treatment. Mucosal vaccination strategies, particularly oral vaccines using polyplexes and microparticulate systems, show promise for inducing both local and systemic immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.

International journal of pharmaceutics·2019
Same author

Nasal vaccination with poly(β-amino ester)-poly(d,l-lactide-co-glycolide) hybrid nanoparticles.

International journal of pharmaceutics·2017
Same author

Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness.

Journal of extracellular vesicles·2015
Same author

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.

Journal of microencapsulation·2015
Same author

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies.

Journal of microencapsulation·2015
Same author

The application of RNAi-based treatments for inflammatory bowel disease.

Drug delivery and translational research·2015

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • DNA immunization presents novel vaccine development avenues for diseases and infections.
  • Mucosal vaccination, including secretory and local approaches, is crucial for combating infections at entry points while stimulating systemic immunity.

Purpose of the Study:

  • To review current and potential applications of polyplex-based mucosal vaccination.
  • To explore strategies for transgene expression in dendritic cells to elicit T-helper and cytotoxic T cell (CTL) responses.
  • To emphasize the development of polyplex-based oral vaccines combined with microparticulate systems.

Main Methods:

  • Review of existing literature on DNA immunization and mucosal vaccine strategies.
  • Analysis of polyplex formulations for enhanced gene delivery to dendritic cells.
  • Investigation of microparticulate systems for oral vaccine delivery.

Main Results:

  • Polyplex-based mucosal vaccines are effective in inducing both local and systemic immune responses.
  • Targeting dendritic cells with transgenes via polyplexes can generate robust T-helper and CTL responses.
  • Integration of microparticulate systems enhances the efficacy of oral DNA vaccines.

Conclusions:

  • Polyplex-based mucosal vaccination strategies hold significant potential for prophylaxis and treatment.
  • Oral DNA vaccines combined with microparticulate systems represent a promising frontier in vaccine development.
  • Further research into these strategies can lead to more effective vaccines against various diseases.

Related Experiment Videos